| A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants B Dearlove, E Lewitus, H Bai, Y Li, DB Reeves, MG Joyce, PT Scott, ... Proceedings of the National Academy of Sciences 117 (38), 23652-23662, 2020 | 241 | 2020 |
| SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity MG Joyce, WH Chen, RS Sankhala, A Hajduczki, PV Thomas, M Choe, ... Cell reports 37 (12), 2021 | 123 | 2021 |
| Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge K Om, D Paquin-Proulx, M Montero, K Peachman, X Shen, L Wieczorek, ... PLoS pathogens 16 (9), e1008764, 2020 | 38 | 2020 |
| Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand M Rolland, S Tovanabutra, B Dearlove, Y Li, CL Owen, E Lewitus, ... PLoS pathogens 16 (2), e1008179, 2020 | 30 | 2020 |
| Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound EM Cale, H Bai, M Bose, MA Messina, DJ Colby, E Sanders-Buell, ... The Journal of Clinical Investigation 130 (6), 3299-3304, 2020 | 28 | 2020 |
| The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes H Bai, Y Li, NL Michael, ML Robb, M Rolland PLoS computational biology 15 (6), e1007056, 2019 | 20 | 2019 |
| RV144 HIV-1 vaccination impacts post-infection antibody responses T Mdluli, N Jian, B Slike, D Paquin-Proulx, G Donofrio, A Alrubayyi, S Gift, ... PLoS Pathogens 16 (12), e1009101, 2020 | 14 | 2020 |
| A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins M Merbah, S Wollen-Roberts, Z Shubin, Y Li, H Bai, V Dussupt, ... Journal of immunological methods 487, 112874, 2020 | 12 | 2020 |
| Timing HIV infection with a simple and accurate population viral dynamics model DB Reeves, M Rolland, BL Dearlove, Y Li, ML Robb, JT Schiffer, P Gilbert, ... Journal of the Royal Society Interface 18 (179), 20210314, 2021 | 11 | 2021 |
| Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection JL Mitchell, J Pollara, K Dietze, RW Edwards, J Nohara, KF N’guessan, ... The Journal of clinical investigation 132 (1), 2022 | 9 | 2022 |
| Coronavirus antibody responses before COVID-19 pandemic, Africa and Thailand Y Li, M Merbah, S Wollen-Roberts, B Beckman, T Mdluli, I Swafford, ... Emerging Infectious Diseases 28 (11), 2214, 2022 | 6 | 2022 |
| HIV-1 infections with multiple founders associate with the development of neutralization breadth E Lewitus, SM Townsley, Y Li, GC Donofrio, BL Dearlove, H Bai, ... PLoS pathogens 18 (3), e1010369, 2022 | 5 | 2022 |
| Factors influencing estimates of HIV-1 infection timing using BEAST B Dearlove, S Tovanabutra, CL Owen, E Lewitus, Y Li, E Sanders-Buell, ... PLOS Computational Biology 17 (2), e1008537, 2021 | 5 | 2021 |
| Acute HIV-1 infection viremia associate with rebound upon treatment interruption T Mdluli, Y Li, S Pinyakorn, DB Reeves, EF Cardozo-Ojeda, A Yates, ... Med 3 (9), 622-635. e3, 2022 | 4 | 2022 |
| RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection E Lewitus, E Sanders-Buell, M Bose, AM O’Sullivan, K Poltavee, Y Li, ... Virus Evolution 7 (2), veab057, 2021 | 2 | 2021 |
| Limited evidence for a relationship between HIV-1 glycan shield features in early infection and the development of neutralization breadth Y Li, H Bai, E Sanders-Buell, V Dussupt, S Townsley, G Donofrio, M Bose, ... Journal of Virology 95 (17), 10.1128/jvi. 00797-21, 2021 | 2 | 2021 |
| Contemporary HIV-1 consensus Env with redesigned hypervariable loops promote antibody binding H Bai, E Lewitus, Y Li, V Dussupt, B Slike, L Mendez-Rivera, A Schmid, ... bioRxiv, 2023.11. 19.567729, 2023 | 1 | 2023 |
| Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens E Lewitus, J Hoang, Y Li, H Bai, M Rolland PLOS Computational Biology 18 (10), e1010624, 2022 | 1 | 2022 |
| HIV-1 Gag, Pol, and Env diversified with limited adaptation since the 1980s E Lewitus, Y Li, H Bai, P Pham, M Rolland Mbio, e01749-23, 2024 | | 2024 |
| Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an … Y Li, M Merbah, S Wollen-Roberts, B Beckman, T Mdluli, DJ Curtis, ... Ebiomedicine 97, 2023 | | 2023 |
